Insider Selling: Balchem Corp. (BCPC) General Counsel Sells 4,000 Shares of Stock
Balchem Corp. (NASDAQ:BCPC) General Counsel Matthew David Houston sold 4,000 shares of the business’s stock in a transaction dated Tuesday, September 20th. The shares were sold at an average price of $67.83, for a total value of $271,320.00. Following the sale, the general counsel now directly owns 20,050 shares of the company’s stock, valued at approximately $1,359,991.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Balchem Corp. (NASDAQ:BCPC) opened at 68.74 on Thursday. The stock has a market capitalization of $2.17 billion, a P/E ratio of 39.06 and a beta of 0.70. The stock has a 50 day moving average price of $67.53 and a 200 day moving average price of $62.85. Balchem Corp. has a 12 month low of $53.11 and a 12 month high of $70.91.
Balchem Corp. (NASDAQ:BCPC) last posted its quarterly earnings data on Friday, August 5th. The company reported $0.44 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.65 by $0.21. The business earned $138.80 million during the quarter, compared to analyst estimates of $134.77 million. Balchem Corp. had a return on equity of 16.85% and a net margin of 10.18%. Equities analysts predict that Balchem Corp. will post $2.53 EPS for the current fiscal year.
Separately, Pivotal Research reissued a “hold” rating and set a $65.00 price target on shares of Balchem Corp. in a report on Sunday, August 7th.
About Balchem Corp.
Balchem Corporation (Balchem) is engaged in the development, manufacture, distribution and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company operates in four segments: SensoryEffects, Animal Nutrition & Health (ANH), Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.